In CRC, superenhancers are enriched not only for BRD4 but also for other proteins, such as the coactivator Mediator, which cooperates with BRD4 in sustaining the expression of cancer-acquired superenhancer genes (e.g., MYC) (Kuuluvainen et al., 2018). The gene discussed is MYC; the disease is colorectal carcinoma.